Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease-Reference-Cited by-同舟云学术

Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease

Published:2020-01-21 Issue:4 Volume:86 Page:801-811
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Chanu Pascal¹^ORCID,Schaefer Franz²,Warady Bradley A.³,Schmitt Claus Peter⁴,Reigner Bruno⁵,Schnetzler Gabriel⁶,Meyer Reigner Sylvie⁶,Eisner Mark⁷,Weichert Arlette⁶,Frey Nicolas⁵

Affiliation:

1. Clinical PharmacologyGenentech/Roche Lyon France

2. University of Heidelberg Heidelberg Germany

3. Children's Mercy Kansas City Kansas City Missouri

4. Center for Pediatric and Adolescent Medicine Heidelberg Germany

5. Roche Pharma Research and Early DevelopmentRoche Innovation Center Basel Switzerland

6. F. Hoffmann‐La Roche Ltd Basel Switzerland

7. Genentech, Inc San Francisco California

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14186

Reference27 articles.

1. The prevalence of anemia in patients with chronic kidney disease

2. Chronic Kidney Disease in Children and Adolescents

3. The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

4. Recombinant human epoetin beta in the treatment of renal anemia;Locatelli F;Ther Clin Risk Manag,2007

5. Erythropoiesis‐stimulating agents for anaemia in adults with chronic kidney disease: a network meta‐analysis;Palmer SC;Cochrane Database Syst Rev,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

2. Chronic Kidney Disease;Avery's Diseases of the Newborn;2024

3. Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective;Clinical Pharmacology & Therapeutics;2023-07-29

4. Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care;Clinical Pharmacology & Therapeutics;2022-12-19

5. Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study;American Journal of Kidney Diseases;2022-12